✉news WorldLaw & Courts first seen 8 h ago, last 1 h ago, peak #3
Liquidia shares fall after US patent court loss to United Therapeutics
Original: Liquidia slumps after US court rules for United Therapeutics in patent fight
Liquidia shares slumped after a US court ruled in favour of United Therapeutics in their ongoing patent dispute. The decision is a setback for Liquidia, whose lead product competes with United Therapeutics' treprostinil-based treatments for pulmonary arterial hypertension. Investors reacted sharply, sending the stock lower as the ruling reduces uncertainty over the rival therapy's market path.
Why now: A court ruling against Liquidia in a high-stakes patent battle directly hit its stock and its competitive outlook.
LiquidiaUnited TherapeuticsUS court
Rank over time, top of the chart is #1. 6 snapshots from 8 h ago to 1 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/532955